Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CyDex Pharmaceuticals

1993 FOUNDED
M&A STATUS
31-40 EMPLOYEES
M&A LATEST DEAL TYPE
$35.5M LATEST DEAL AMOUNT
Description

Provider of drug delivery technology. The company's drug delivery technology uses four Captisol-enabled products commercialized by Pfizer and Bristol-Myers Squibb (BMS) to address asthma, depression, allergy, cancer and arrhythmia disease states.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Parent Company
Primary Office
  • 10513 West 84th Terrace
  • Lenexa, KS 66214
  • United States

+1 (913) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CyDex Pharmaceuticals’s full profile, request a free trial.

CyDex Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 26-Jan-2011 $35.5M 0000 000.00 Completed Clinical Trials - Phase 2
4. Later Stage VC 24-Mar-2010 000.00 0000 Completed Generating Revenue
3. IPO 28-Oct-2008 0000 Cancelled Clinical Trials - Phase 2
2. Early Stage VC (Series B) 17-Aug-2004 $17M $29M 000.00 Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 11-Oct-2000 $12M $12M 000.00 Completed Clinical Trials - Phase 2
To view this company’s complete deal history including valuation and funding, request access »

CyDex Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A1 0,000,000 00.000000 00 00 00 00 00 0.000
Series A 16,464,622 $0.010000 7% $0.73 $0.73 1x $0.73 15.99%
To view this company’s complete Cap Table, request access »

CyDex Pharmaceuticals Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Clariden Investment Venture Capital Minority 000 0000 000000 0
Eastman Ventures Corporate Venture Capital Minority 000 0000 000000 0
Edelman Financial Services Asset Manager Minority 000 0000 000000 0
Individual Investor Angel (individual) Minority 000 0000 000000 0
Private Equity Direct Finance PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »